MLICM
VMD icon

Metropolitan Life Insurance Company (MetLife)’s Viemed Healthcare VMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,876
Closed -$17.7K – 2050
2024
Q1 		$17.7K Hold
1,876
– – ﹤0.01% 1922
2023
Q4 		$14.7K Hold
1,876
– – ﹤0.01% 2042
2023
Q3 		$12.6K Hold
1,876
– – ﹤0.01% 2110
2023
Q2 		$18.3K Buy
+1,876
New +$19.1K ﹤0.01% 1979
2021
Q2 		– Sell
-11,344
Closed -$115K – 2890
2021
Q1 		$115K Buy
11,344
+8,433
+290% +$79.4K ﹤0.01% 2362
2020
Q4 		$22.6K Sell
2,911
-4,210
-59% -$37K ﹤0.01% 2510
2020
Q3 		$61.5K Sell
7,121
-5,233
-42% -$52.8K ﹤0.01% 2438
2020
Q2 		$119K Buy
+12,354
New +$96K ﹤0.01% 2147

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Viemed Healthcare (VMD) in Q2 2024, closing a stake of 1,876 shares — an estimated $17.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VMD in Q2 2020 and held it in 8 quarters. The position peaked at $119K in Q2 2020. 116 funds tracked by Wall St. Rank hold VMD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Viemed Healthcare position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,876 Viemed Healthcare shares in Q2 2024, an estimated $17.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Viemed Healthcare in Q2 2020 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Viemed Healthcare position peaked at $119K in Q2 2020.
  • 116 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.